Managing IP is part of the Delinian Group, Delinian Limited, 8 Bouverie Street, London, EC4Y 8AX, Registered in England & Wales, Company number 00954730
Copyright © Delinian Limited and its affiliated companies 2023

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

EIP hires litigation partner from Teva


UK firm EIP has hired Matthew Jones as a partner in its London office, in the latest in a string of expansive moves by the firm

M Jones

Jones (right) joins from Teva Pharmaceuticals Europe where he worked on patent litigation, including Generics [UK] v Yeda & Teva over the drug Copaxone. The Court of Appeal ruled on the case in July 2013.

Jones has worked on other patent areas in the past, including electronics and telecoms. He worked alongside EIP's head of litigation Gary Moss at both McDermott Will & Emery and Taylor Wessing.

EIP opened an office in the US in May 2013, in San Diego – the first UK IP law firm to do so. It has also said it will open an office in Düsseldorf, Germany later this year.

The firm now has 18 partners, of which five work on litigation under the EIP Legal side of the firm. The remainder are patent and trade mark attorneys.

more from across site and ros bottom lb

More from across our site

The IPO must change its approach and communicate with IP owners about its attempts at clearing up the trademark register
Counsel are looking at enforceability, business needs and cost savings when filing for patents overseas
James Perkins, member at Cole Schotz in Texas, reveals how smaller tech companies can protect themselves when dealing with larger players
We provide a rundown of Managing IP’s news and analysis coverage from the week, and review what’s been happening elsewhere in IP
The EUIPO management board must provide the Council of the EU with a performance assessment before it can remove the executive director
The European Commission confirmed that plans for a unitary SPC will be published in April alongside reforms to the SEP system
The court held that SEP implementers could be injuncted or directed to pay royalties before trial if they are deemed to be unwilling licensees
Patentees should feel cautious optimism over the EPO Enlarged Board of Appeal’s decision in G2/21, say European patent attorneys
Significant changes to the standard of law are unlikely, say sources, who note that some justices seemed sceptical that the parties disagreed on the legal standard
Sources say the High Court of Australia’s ruling that reputation is immaterial in trademark infringement cases could stop famous brands from muscling out smaller players